Orchid Chemicals & Pharmaceuticals Ltd. formulation facilities Cephalosporin & Penicillin Injectable have received approval from the Medicines Control Council (MCC), South Africa.

The Chennai-based, global pharma major Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) today announced that its formulation facilities, comprising the Cephalosporin plant and Penicillin plant have been approved by the Medicines Control Council (MCC), South Africa. These facilities manufacture a range of Cephalosporin and Penicillin injections.

The approval validates the compliance standards of Orchid’s facilities in line with the Good Manufacturing Practices (GMP) regulations. This approval will pave the way for Orchid’s entry into the South African market based on specific product filings and approvals.

Orchid is integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery. From the very inception, Orchid has been investing aggressively for establishing modern research and manufacturing facilities aimed at global markets, thus emerging as a world-class pharmaceutical company covering the entire value chain from “Discovery to Delivery”.